[Erythrodermic psoriasis after COVID-19]. / Erythroderme Psoriasis nach COVID-19-Erkrankung.
Hautarzt
; 73(2): 156-159, 2022 Feb.
Article
in German
| MEDLINE | ID: covidwho-1568342
ABSTRACT
We present a clinical case of a patient with acutely exacerbated erythrodermic psoriasis vulgaris after symptomatic infection with SARS-CoV2 (severe acute respiratory syndrome coronavirus 2). Various factors are already known that can lead to an exacerbation of psoriasis, such as drugs or infections with, for example, streptococcus. An association between psoriasis and an infection with SARS-CoV2 has been described so far in individual case reports, in which, however, drug treatment with for example hydroxychloroquine, a known trigger of psoriasis, often took place. Later cases of exacerbation of psoriasis, partly as pustular psoriasis have been published also without drug induction. However we present for the first time a case of erythrodermic psoriasis triggered by COVID-19 (coronavirus disease 2019) without an obvious drug trigger.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Psoriasis
/
COVID-19
Type of study:
Case report
/
Diagnostic study
/
Prognostic study
Limits:
Humans
Language:
German
Journal:
Hautarzt
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS